Skip to content

Principal Investigators

David A. Alagpulinsa, PhD

Principal Investigator

Dr. Alagpulinsa is an Instructor at Massachusetts General Hospital and Harvard Medical School. He earned a bachelor’s degree in Pharmacy from KNUST, Ghana, and a PhD in Interdisciplinary Biomedical Sciences from the University of Arkansas for Medical Sciences, USA.

Huabiao Chen, PhD

Principal Investigator

Dr. Chen joined VIC in 2015 with a focus on mesenchymal stem/stromal cells (MSCs) and MSC-derived intracellular vesicles/exosomes for therapy of various cancers. He is actively involved in the preclinical development of vaccines and immunotherapies for cancer by regrouping and redirecting immune responses in the tumor microenvironment to combat cancer.

Tianhong Dai, PhD

Principal Investigator

Dr. Dai is an Associate Member of VIC. His current research is focused on developing light-based technologies for preventing and treating infectious diseases. Particularly, he is considered a world leader who is responsible for launching the new research area of antimicrobial blue light therapy for multidrug-resistant infections.

Jeffrey A. Gelfand, M.D.

Principal Investigator

Dr. Gelfand is a Physician in the Infectious Diseases Division at Massachusetts General Hospital (MGH) and Professor of Medicine, Part Time at Harvard Medical School. He is a Senior Scientist in the MGH Vaccine and Immunotherapy Center.

Shibani S. Mukerji, M.D., Ph.D

Principal Investigator

Dr. Mukerji is a board-certified neurologist, Associate Director of the Mass General Hospital Neuro-infectious Diseases Unit, and Assistant Professor in Neurology at Harvard Medical School. She is an MD and PhD graduate of Case Western Reserve School of Medicine.

Mark C. Poznansky, MD, PhD

Principal Investigator

Dr. Poznansky is a physician scientist and medical innovator whose work bridges academic discovery and clinical care. As a leader in the field of leukocyte migration and the modulation of leukocyte trafficking and function, he has linked discovery with the development of new vaccines and immunotherapies for cancer, pandemic viruses and immune mediated diseases including type 1 diabetes and ALS.

Patrick Reeves, PhD

Principal Investigator

Dr. Patrick Reeves is a Principal Investigator in the Vaccine and Immunotherapy Center, Instructor in Investigation at Massachusetts General Hospital, and Instructor of Medicine at Harvard Medical School. Dr. Reeves’ investigations into immune modulating therapies and vaccine development is informed by his training immunology, microbiology, and cell biology.

Ruxandra F. Sîrbulescu, PhD

Principal Investigator

Dr. Ruxandra Sîrbulescu is a Principal Investigator in the Vaccine and Immunotherapy Center, Instructor in Investigation at Massachusetts General Hospital, and Instructor in Medicine at Harvard Medical School. Dr. Sîrbulescu is a trained neurobiologist whose research interests focus on regenerative medicine.